Maha Elgaafary

A Randomized Controlled Study Of Favipiravir Vs Hydroxychloroquine In COVID-19 Management: What Have We Learned So Far?

M. El-Sayed, H. Elghazaly, A. Sherief, 2020 .

Osteoporosis clinical practice guideline: romosozumab for treating severe osteoporosis – an update by the Egyptian Academy of Bone Health

Y. E. Miedany, S. Mahran, M. Eissa, 2022, Egyptian Rheumatology and Rehabilitation.

RETRACTED ARTICLE: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial

M. El-Sayed, H. Elghazaly, A. Sherief, 2021, Scientific Reports.

Development of outcome measures for giant cell arteritis for use in clinical trials and standard practice

D. Palmer, Y. El Miedany, M. Elgaafary, 2023, Clinical Rheumatology.